This is what I don't want to hear. First they will tell us "we failed a test"
After taking 10 weeks so far for something that should've been completed in 30 days, test failure (or would it be cell growth failure) is 50:50 currently.
More entertaining in the future... is Kenny announcing the tests have completed. Then SHs get to guess when the mythical IND has gone in. If ever submitted for a Phase 2b, it will be rejected. Then comes too much fun, as Kenny sits on the rejection for months Later claims it wasn't a material event. Just like he did with the patent. Brings out the CRO for an overdue PR pump about a flurry of activity on the clinical side. SH speculation soars. Then announces the rejection. But everything is under control, as they will need time to resubmit it for a Phase 1.
Throughout all the gyrations, traders will come&go. 3rd party dumpees get to dump into volume, and trot back to Kenny asking for more discounted shares. Multiple 10Qs will also come&go showing not enough cash for even 1 "pay as you go" mythical patient, for a still non-existent mythical CT. Before ya know it, the calendar will read 14-Jan 2021.
News 
Market Data 
Discover 
